Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain.
CIBER en Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Cardiovasc Res. 2022 Jan 29;118(2):503-516. doi: 10.1093/cvr/cvab055.
Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare laminopathy caused by expression of progerin, a lamin A variant, also present at low levels in non-HGPS individuals. HGPS patients age and die prematurely, predominantly from cardiovascular complications. Progerin-induced cardiac repolarization defects have been described previously, although the underlying mechanisms are unknown.
We conducted studies in heart tissue from progerin-expressing LmnaG609G/G609G (G609G) mice, including microscopy, intracellular calcium dynamics, patch-clamping, in vivo magnetic resonance imaging, and electrocardiography. G609G mouse cardiomyocytes showed tubulin-cytoskeleton disorganization, t-tubular system disruption, sarcomere shortening, altered excitation-contraction coupling, and reductions in ventricular thickening and cardiac index. G609G mice exhibited severe bradycardia, and significant alterations of atrio-ventricular conduction and repolarization. Most importantly, 50% of G609G mice had altered heart rate variability, and sinoatrial block, both significant signs of premature cardiac aging. G609G cardiomyocytes had electrophysiological alterations, which resulted in an elevated action potential plateau and early afterdepolarization bursting, reflecting slower sodium current inactivation and long Ca+2 transient duration, which may also help explain the mild QT prolongation in some HGPS patients. Chronic treatment with low-dose paclitaxel ameliorated structural and functional alterations in G609G hearts.
Our results demonstrate that tubulin-cytoskeleton disorganization in progerin-expressing cardiomyocytes causes structural, cardiac conduction, and excitation-contraction coupling defects, all of which can be partially corrected by chronic treatment with low dose paclitaxel.
哈钦森-吉尔福德早衰综合征(HGPS)是一种罕见的核纤层病,由前胶原(progerin)表达引起,前胶原是核纤层蛋白 A 的一种变体,在非 HGPS 个体中也以低水平存在。HGPS 患者过早衰老和死亡,主要死于心血管并发症。先前已经描述了前胶原诱导的心脏复极化缺陷,尽管其潜在机制尚不清楚。
我们在表达 progerin 的 LmnaG609G/G609G(G609G)小鼠的心脏组织中进行了研究,包括显微镜检查、细胞内钙动力学、膜片钳、体内磁共振成像和心电图。G609G 小鼠的心肌细胞显示微管细胞骨架紊乱、t 小管系统破坏、肌节缩短、兴奋-收缩偶联改变以及心室增厚和心指数降低。G609G 小鼠表现出严重的心动过缓,以及房室传导和复极化的显著改变。最重要的是,50%的 G609G 小鼠出现了心率变异性改变和窦房结阻滞,这都是心脏过早衰老的显著标志。G609G 心肌细胞的电生理改变导致动作电位平台升高和早期后除极爆发,反映出钠电流失活减慢和 Ca+2 短暂持续时间延长,这也可能有助于解释一些 HGPS 患者的 QT 延长。低剂量紫杉醇的慢性治疗改善了 G609G 心脏的结构和功能改变。
我们的结果表明,前胶原表达的心肌细胞中微管细胞骨架紊乱导致结构、心脏传导和兴奋-收缩偶联缺陷,这些缺陷都可以通过低剂量紫杉醇的慢性治疗得到部分纠正。